Clinical Trial Update: A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BL-B01D1 in combination with a PD-1 monoclonal antibody in locally advanced or metastatic non-small cell lung cancer and nasop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• BL-B01D1
• PD-1 monoclonal antibody

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma | Phase 2 | Status: RECRUITING